Increased GM‐CSF‐producing NCR^‐ ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease

Inflammatory bowel disease (IBD) is characterised by dysregulated mucosal immune responses associated with genetic, environmental and microbial factors. Recent therapies targeting key inflammatory mediators such as tumor necrosis factor (TNF)-α emphasise the importance of innate immunity in the development of IBD.We examined the distribution of innate immune cells such as innate lymphoid cells (ILCs) and myeloid cells in the intestinal...